Progression of potentially aggressive pituitary neuroendocrine tumors after radiotherapy: risk factors, management, and outcomes
Fabio Bioletto(Department of Medical Sciences), Guillaume Assié(Centre National de la Recherche Scientifique), Bertrand Baussart(Centre National de la Recherche Scientifique), Nesrine Benanteur(Inserm), C. Garcia(Hôpital d'Instruction des Armées Bégin), Anne Jouinot, Laurence Guignat(Hôpital Cochin), Caroline Bogeat(Hôpital Ambroise-Paré), Mirella Hage(Université de Versailles Saint-Quentin-en-Yvelines), Chiara Villa(Centre National de la Recherche Scientifique), Lionel Groussin(Université Paris Cité), Maxime Barat(Université Paris Cité), Valentin Calugaru(Institut Curie), Xavier Bertagna(Centre National de la Recherche Scientifique), Jérôme Bertherat(Centre National de la Recherche Scientifique), Julian Jacob(Sorbonne Université), Jennifer Arrondeau(Hôpital Cochin)
Cited by 3
Related Papers
SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma
|Cancer Cell|2013|772
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma
|Cancer Cell|2016|665
SDHA is a tumor suppressor gene causing paraganglioma
|Human Molecular Genetics|2010|651
An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis
|The Lancet Oncology|2009|536
Constitutive Activation of PKA Catalytic Subunit in Adrenal Cushing's Syndrome
|New England Journal of Medicine|2014|434